DavidLaxsonMDFACC, FAHA

PubMed

• 8 citations
  Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-aspirin-induced platelet dysfunction.
  Gerhard J. Johnson, Anish V. Sharda, Gundu H. R. Rao, Mark H. Ereth, David D. Laxson
  Clinical and Applied Thrombosis/hemostasis. 2012-03-01
• 19 citations
  Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
  Timothy D. Henry, Daniel Satran, Lorri L. Knox, Cheryl L. Iacarella, David D. Laxson
  American Heart Journal. 2001-10-01
• 17 citations
  Recovery of transmural and subepicardial wall thickening after subendocardial infarction
  D. C. Homans, Todd J. Pavek, David D. Laxson, Robert J. Bache
  Journal of the American College of Cardiology. 1994-10-01

Journal Articles

• Measurement of Shear-Activated Platelet Aggregate Formation in Non-anticoagulated Blood: Utility in Detection of Clopidogrel-Aspirin-Induced Platelet Dysfunction  
  G.J. Johnson, A.V. Sharda, G.H.R. Rao, M.H. Ereth, D.D. Laxson, W.G. Owen, Clinical and Applied Thrombosis/Hemostasis, 10/17/2011
• Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A  
  TIMI 11A Investigators, JACC, 1/1/1997
• Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or post infarction angina  
  Bittle JA et al, NEJM, 1/1/1995
• Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR Study, a multicenter, double blind, placebo controlled trial ...  
  Faxson DP et al, J Am Coll Cardiol, 1/1/1995
• Constrictive pericardial disease secondary to epicardial implantable cardiac defibrillator patches: Treatment with pericardial stripping and implantation of a nonthora...  
  Lurie KL, Schultz J, Remole S, Asso A, Pineda E, Benditt D, Fetter J, Laxson DD, Am Heart J, 1/1/1994
• Recovery of transmural and subepicardial wall thickening following subendocardial infarction  
  Homans DC, Pavek T, Laxson DD, Bache RJ, J Am Col Cardiol, 1/1/1994
• Regional difference in sympathetic reinnervation after human orthotopic cardiac transplantation  
  Wilson RF, Laxson DD, Christensen BV, McGinn AL, Kubo SH, Circulation, 1/1/1993
• Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise  
  Dunker DJ, Laxson DD, Lindstrom P, Bache RJ, Cardiovascular Res, 1/1/1993
• Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise  
  Laxson DD, Homas DL, Bache RJ, Am J Physiol (Heart Circ Physiol), 1/1/1993
• Endothelial function in well-developed canine coronary collateral vessels  
  Altman J, Dulas D, Pavek T, Laxson DD, Homans DC, Bache RJ, Am J Physiol (Heart Circ Physiol), 1/1/1993
• Caveat emptor: A clinician's guide to assessing the physiologic significance of arterial stenosis  
  Wilson RF, Laxson DD, Card Cathet Diag, 1/1/1993
• Coronary vasodilator reserve in ischemic myocardium of the exercising dog  
  Laxson DD, Dai XZ, Homans DC, Bache RJ, Circ, 1/1/1992
• Evidence for sympathetic innervation after orthotopic cardiac transplantation in humans  
  Wilson RF, Christensen BV, Olivari MT, Simon A, White CW, Laxson DD, Circ, 1/1/1991
• The effect of exercise intensity on regional function during and following exercise induced ischemia  
  Homans DC, Laxson DD, Bache RJ, Circ, 1/1/1991
• The effects of adenosine on human coronary arterial circulation  
  Wilson RF, Wyche K, Christensen BV, Zimmer SD, Laxson DD, Circ, 1/1/1990
• Coronary atriolar vasoconstriction in myocardial ischemia: Coronary vasodilator reserve during ischemia  
  Bache RJ, Laxson DD, Eur Heart J, 1/1/1990
• Effect of a coronary stenosis on myocardial blood flow during exercise in the chronically pressure overloaded hypertrophied left ventricle  
  Bache RJ, Wright L, Laxson DD, Dai XZ, Circulation, 1/1/1990
• The role of a1-and a2-adrenergic receptors in mediating coronary vasoconstriction in hypoperfused ischemic myocardium during exercise  
  Laxson DD, Dai XZ, Nomans DC, Bache RJ, Circ Res, 1/1/1989
• Cumulative deterioration of myocardial function after repeated episodes of exercise induced ischemia  
  Homans DC, Laxson DD, Sublett E, Lindstrom P, Bache RJ, Am J Physiol, 1/1/1989
• Effects of atrial natriuretic peptide on coronary vascular resistance in the awake dog  
  Laxson DD, Dai XZ, Schwartz JS, Bache RJ, J Am Coll Card, 1/1/1988
• Join now to see all

Abstracts/Posters

• Measurement of Platelet Activation in Response to Shear Stress in Patients with Arterial Vascular Risk Factors and Disease.
  Gerhard JJ, Gundu HR, Raveendran G, Laxson DD, Helmer GA, Haworth B, Platelets International Sympsium, 10/15/2008
• Are ACTs helpful in the management of anticoagulation with low molecular weight heparin?
  Henry TD, Knox LK, Iacarella CL, Laxson DD, J Am Coll Cardiol, 1/1/1997
• Evaluation of the oral glycoprotein IIb/IIIa antagonist Ro 48-3657 in patients post acute coronary syndromes: Primary results of the TIMI 12 trial.
  Cannon CP, Novotny WF, McCabe CH, et al and the TIMI Investigators, Circulation, 1/1/1996
• Bleeding risk with platelet inhibition using tirofiban: the RESTORE trial.
  Anderson VH, Bertrand ME, Hall BH, et al for the RESTORE Investigators, Circulation, 1/1/1996
• Dose ranging trial for enoxaparin for unstable angina: results of TIMI 11A.
  Antman EM, McCabe CH, Marble SJ, et al-the TIMI 11A group, Circulation, 1/1/1996
• The post-PTCA frame count and mortality in RESTORE.
  Gibson M, Goel M, Dotani I, et al for the RESTORE Investigators, Circulation, 1/1/1996
• Time course of reduction in adverse events following angioplasty using a IIb/IIIa receptor blocker, tirofiban: the RESTORE trial.
  King SB, Willerson JT, Ross AM, et al for the RESTORE Investigators, Circulation, 1/1/1996
• Hyperglycemia impairs coronary microvascular endothelium-dependent vasodilation.
  Hollenbaugh D, Laxson DD, Circulation, 1/1/1995
• Coronary angioplasty results in microvascular vasoconstriction.
  Laxson DD, Pavek T, Crampton M, Zhang XW, Clin Res, 1/1/1994
• Can sympathetic reinnervation after human cardiac transplantation affect left ventricular function.
  Burke MN, Homans DC, Laxson DD, Christensen BV, Kubo SH, Wilson RF, Circulation, 1/1/1992
• Chest pain after successful angioplasty: Evidence for microvascular dysfunction.
  Henry TD, Laxson DD, McGinn AZ, Zimmer SD, Wilson RF, J Am Coll Cardiol, 1/1/1992
• Reduced resting epicardial coronary constrictor tone early after cardiac transplantation.
  McGinn AL, Christensen BV, Meyer SM, Simon A, Kubo SH, Laxson DD, Wilson RF, Internat Soc Heart Transplantation 11th Scientific Sessions, 4/1/1991
• Sympathetic reinnervation after cardiac transplantation in humans: Time course and regional heterogeneity.
  Wilson RF, McGinn AL, Laxson DD, Christensen BV, Kubo SH, Internal Soc Heart Transplantation, 11th Scientific Sessions, 4/1/1991
• Nitroglycerin induced coronary vasodilation is impaired early after cardiac transplantation.
  McGinn AL, Christensen BV, Meyer SM, Simon A, Kubo SH, Laxson DD, Wilson RF, J Am Coll Cardiol, 1/1/1991
• Endothelial function in well-developed canine coronary collateral vessels.
  Altman J, Dulas D, Laxson DD, Homans DC, Bache RJ, Circ, 1/1/1991
• Regional differences in sympathetic reinnervation after cardiac transplantation.
  Wilson RF, McGinn AL. Laxson DD, Christensen BV, Simon AB, Johnson TH, Kubo SH, Circ, 1/1/1991
• Can sympathetic reinnervation affect coronary resistance after human cardiac transplantation?
  McGinn Al, Meyer SM, Christensen BV, Simon AB, Johnson TH, Kubo SH, Laxson DD, Wilson RF, Circ, 1/1/1991
• Effects of a coronary stenosis on transmural myocardial high energy phosphates and systolic function.
  Path GJ, Tristani-Firouzi M, Zhang J, Homans DC, Laxson DD, Robitaille PM, Merkle H, Lindstrom P, Pavek T, From AH, Bache RJ, Ugurbil K, Circ, 1/1/1990
• Acute, but not chronic, reduction of myocardial blood flow results in marked subendocardial underperfusion during exercise.
  Bache RJ, Foreman BF, Pavek T, Lindstrom P, Laxson DD, Homans DC, Circ, 1/1/1990
• Vasoconstriction of collateral vessels by serotonin and U46619.
  Wright L, Dai XZ, Laxson DD, Homans DC, Bache RJ, Circ, 1/1/1989
• Effects of adenosine on the coronary circulation in humans.
  Wilson RF, Christensen B, Zimmer SD, Laxson DD, White CW, J Am Coll Cardiol, 1/1/1989
• Endogenous adenosine contributes to coronary vasodilation in ischemic myocardium during exercise.
  Laxson DD, Dai XZ, Stark RP, Bache RJ, Circ, 1/1/1989
• 31P NMR spectroscopy detects regional ischemia during graded coronary stenosis.
  Path G, Robitaille PM, Tristani-Firouzi M, Merkle H, Laxson DD, Homans DC, Sublett E, Zhang J, Lindstrom P, From AHL, Bache RJ, Ugurbil K, Circ, 1/1/1989
• Recovery of subepicardial and transmural function following subendocardial infarct.
  Homans DC, Dai XZ, Laxson DD, Sublett E, Pavek T, Bache RJ, Circ, 1/1/1989
• Alpha-Adrenergic Coronary Vasoconstrictor Receptor Subtypes in Awake Dogs.
  Dai XZ, Laxson DD, Hautamaa PV, Schwartz JS, Bache RJ, American College of Cardiology, 37th Scientific Session, 3/1/1988
• Join now to see all